Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China
· Delayed Price · Currency is CNY 64.30
-0.37 (-0.57%)
May 6, 2025, 2:45 PM CST
SHA:688399 Revenue
In the year 2024, Jiangsu Bioperfectus Technologies had annual revenue of 349.61M CNY, down -13.29%. Jiangsu Bioperfectus Technologies had revenue of 81.52M in the quarter ending December 31, 2024, a decrease of -35.68%.
Revenue
349.61M
Revenue Growth
-13.29%
P/S Ratio
10.48
Revenue / Employee
590.56K
Employees
592
Market Cap
3.66B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |